Aura Biosciences, Inc. Annual Operating Income (Loss) in USD from 2020 to 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Aura Biosciences, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2020 to 2024.
  • Aura Biosciences, Inc. Operating Income (Loss) for the quarter ending December 31, 2024 was -$27.8M, a 12.2% decline year-over-year.
  • Aura Biosciences, Inc. Operating Income (Loss) for the twelve months ending December 31, 2024 was -$96.1M, a 13.1% decline year-over-year.
  • Aura Biosciences, Inc. annual Operating Income (Loss) for 2024 was -$96.1M, a 13.1% decline from 2023.
  • Aura Biosciences, Inc. annual Operating Income (Loss) for 2023 was -$85M, a 41% decline from 2022.
  • Aura Biosciences, Inc. annual Operating Income (Loss) for 2022 was -$60.3M, a 71.1% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$96.1M -$11.1M -13.1% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-24
2023 -$85M -$24.7M -41% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-24
2022 -$60.3M -$25M -71.1% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-27
2021 -$35.3M -$13M -58.7% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-15
2020 -$22.2M Jan 1, 2020 Dec 31, 2020 10-K 2022-03-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.